| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269272 | HPB | 2013 | 6 Pages |
Abstract
The above findings illustrate that different approaches to the assessment and reporting of the retroperitoneal margin can change the results and adversely affect the final statistics used in pancreatic cancer studies and clinical trials.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Vlad Maksymov, Michael Hogan, Mahmoud A. Khalifa,